Alzheimer's Disease International (ADI) is the global voice on dementia. We raise awareness by supporting Alzheimer associations and individuals worldwide.
We’re delighted to offer three pairs of tickets to ADI’s End of Year Forecast event, taking place in London on 9 December.
This year, we are privileged to welcome Professor Miia Kivipelto, a world-leading expert in Alzheimer’s disease and dementia risk reduction, for a special conversation with Chris Lynch, ADI’s Deputy CEO and Director of Policy, Research & Communications.
Together, they will explore how advances in dementia risk reduction are intersecting with exciting developments in early diagnostics and new treatments – and how these innovations could shape a new, more personalised approach to dementia prevention, health and care.
We are at a pivotal moment in our understanding of Alzheimer’s disease and dementia. This special one-hour discussion offers a unique opportunity to hear from one of the leading voices in the field, gain fresh insights and, importantly, put your own questions to Professor Kivipelto.
The event will be of particular interest to anyone working across the Alzheimer’s and dementia landscape, including researchers, healthcare professionals, care providers, policymakers, government representatives and the media. We would also particularly welcome people living with dementia and family carers.
The event, hosted at the offices of our partner Edelman Media, concludes with festive nibbles and drinks and an opportunity to speak to fellow attendees.
To register your interest, please email [email protected] including your name, job title and organisation (or university/research institution, where applicable).
Please note that attendees will need to make their own travel arrangements.
Today, ADI’s Regional Director for Asia Pacific, DY Suharya was invited as an honoree speaker to deliver remarks as part of the 1st Annual Scientific Meeting of Dementia Alliance Malaysia (DAMAI), held under the leadership of Professor Maw Pin Tan.
The Director of Family Health Development from the Ministy of Health, Dr Norsiah binti Ali officiated the inaugural event and stated the Ministry’s commitment to support people with dementia in Malaysia in partnership with all.
Held at Monash University, the meeting brought together 70 participants under the theme: Building Malaysia’s Dementia Eco system: Policy, Research, Community, Care & Innovation.
The event also welcomed ADI Member, Alzheimer’s Disease Foundation Malaysia (ADFM) to support progress towards the key milestones of a Dementia-Ready Malaysia by 2050, while strengthening regional cooperation through ASEAN Health Cluster 1.
Prior to the meeting DY was also interviewed by BFM Podcast and had the opportunity to discuss the potential regional dialogue on dementia scheduled in late 2027.
ADI looks forward to continuing to work with partners in Malaysia to improve the lives of people living with dementia and their carers across the country.
The 2024 Lancet Commission on dementia prevention, intervention and care identified 14 modifiable risk factors that together could account for around 45% of dementia cases worldwide.
This percentage is an estimate of how many cases could potentially be prevented if all risk factors were addressed, offering national health systems an indication on where risk reduction strategies may have the greatest impact if prioritised.
The factors linked to the greatest share of cases are hearing loss and high LDL cholesterol in midlife, each accounting for 7%. Close behind, at 5% each, are less education in early life and social isolation in later life.
Want to have the opportunity to learn more from a world-leading expert?
On 09 December 2026 at 1pm GMT, ADI’s End of Year Forecast livestream, with guest expert Professor Miia Kivipelto, will highlight tangible evidence towards the efficacy of national dementia prevention programmes and how these can be leveraged within health systems globally.
Register for this free event today: https://t.co/6IIfaNIJsE
ADI would like to congratulate the Kiang Wu Nursing College (KWNC) on the establishment of the Kiang Wu Nursing and Health Teaching and Research Centre and the Kiang Wu Vocational Skills Training School in Hengqin, officially inaugurated on 7 November 2026, with ADI Chief Executive Officer, Dr Faith Mwangi-Powell delivering congratulatory remarks at the opening ceremony.
As the first ADI-accredited education provider, KWNC has played an important role in supporting the development of the ADI Accreditation Programme and strengthening international collaboration in dementia education.
This significant milestone further expands opportunities for professional training, research and capacity building across the Greater Bay Area. The successful delivery of ADI-accredited courses, reaching nearly 200 participants, reflects KWNC’s continued commitment to high-quality, person-centred dementia care.
Through the ADI Accreditation Programme, we are proud to support continued growth in strengthen dementia education, and look forward to further strengthening our partnership in advancing dementia education, professional standards and collaborative learning across the region.
More information on ADI Accreditation Programme: https://t.co/NdVGBy6cpR
On 9–10 November, Ministry of Health representatives, Pan American Health Organization (PAHO) country office delegates and presidents of ADI member associations from Argentina, Brazil, Chile, Colombia, Costa Rica, the Dominican Republic, Mexico, Peru and Uruguay are gathering in Mexico City for the Regional Technical Meeting on Dementia in the Americas, alongside international experts from the WHO, PAHO and senior staff from the ADI member associations in the United States and Ecuador.
ADI Regional Director for the Americas, Diego Aguilar, highlighted the essential role of Alzheimer and dementia associations in advocacy, strengthening regional cooperation, supporting families, and ensuring the meaningful participation of people living with dementia in policymaking.
Throughout the first day, participants reviewed progress and challenges in national dementia policies, awareness and stigma reduction, risk reduction, timely diagnosis, treatment, care, and caregiver support. Discussions also explored information systems, research, and innovation, alongside country experiences from Mexico, Chile, and Brazil.
Key priorities emerging from the regional discussion include:
•Importance of regional cooperation to develop coordinated responses across the Americas
•Positioning dementia as a public health priority
•Integrating brain health, risk reduction and prevention to primary healthcare and policies
•Closing gaps in diagnosis and care
These exchanges helped identify common challenges, promising practices and opportunities for regional cooperation to accelerate the implementation of the WHO Global Action Plan on Dementia, extended to 2031, recognising the essential role of civil society and regional partnerships in turning shared commitments into concrete action.
ADI is delighted to announce that registration is now open for our third annual End of Year Forecast!
This year, we will explore the vital role of dementia risk reduction and its intersection with treatment, care and support, examining how these approaches can work together to improve outcomes for people affected by dementia.
Taking place on 09 December, ADI Deputy CEO, Chris Lynch, will be joined by special guest, renowned Professor of Clinical Geriatrics at the Karolinska Institutet and founder of the landmark World-Wide FINGERS dementia prevention initiative, Prof Miia Kivipelto, to discuss the facts, dispel myths, and explore the global challenges and opportunities surrounding dementia risk reduction.
We will be asking poignant questions about how an individual can reduce their dementia risk, what genetic risk is, what can be achieved on a national scale to help countries increase prevention rates across populations, and how prevention strategies can be leveraged into existing treatment and support systems around the world.
Register today: https://t.co/6IIfaNIJsE
There is just under one week remaining to apply to be ADI’s next Digital Lead.
The successful candidate will have confidence with, and experience using digital platforms including social media, email delivery and website content. They will lead on ADI’s digital outputs including the main website, e-Comms, social media and blogs, including the development of visual content. They will also lead on the management, delivery and analysis of ADI’s monthly e-newsletter, Global Perspective.
Learn more & apply at: https://t.co/HNffu554Vh
To mark her first month as CEO of ADI, Dr Faith Mwangi-Powell is launching a new blog series, sharing her perspectives on the challenges, opportunities and developments shaping the future of dementia prevention, care, research and policy.
In her first blog, Faith reflects on the potential of emerging Alzheimer’s disease treatments and biomarkers to transform dementia diagnosis and care, while emphasising the importance of ensuring these scientific breakthroughs are accessible to everyone, regardless of where they live.
Faith also shares insights from her recent engagement at the World Dementia Council Summit, reflecting on the discussions and priorities shaping the global dementia agenda.
Read the blog: https://t.co/jooQcJZ9Pq
Yesterday, ADI’s Head of Policy and Communications, Lewis Arthurton, delivered three statements at the 76th WHO Regional Committee for Europe in Copenhagen, Denmark, calling for greater recognition of dementia in regional health policies. The statements addressed Member States on three key priorities:
🔴 ADI welcomed the proposed European Ageing is Living strategy (2026–2030). While dementia is not a normal part of ageing, age remains its greatest risk factor. The strategy’s focus on prevention, stronger health and care systems, age-friendly environments and tackling ageism are all essential components to addressing dementia’s rising impact.
🔴 ADI expressed support for the proposed Roadmap for Action on Artificial Intelligence in Health (2026–2033), recognising the opportunities AI offers to improve support and assistive technologies for people living with dementia. However, ADI also cautioned that AI is not the panacea and that AI must complement, rather than replace, person-centred care and long-term support.
🔴 ADI raised concerns about the proposed direction of the WHO European Region's new NCD strategy, which proposes including dementia within a separate new mental health and wellbeing framework, rather than embedded within the NCD strategy. Building on ADI's successful advocacy for dementia's inclusion in the fourth UN Political Declaration on NCDs, ADI urged Member States to reconsider this approach, and move away from an emphasis on premature mortality that fails to reflect the full impact of conditions such as dementia.
This week, ADI team members travelled to Dublin, Ireland to attend the annual Alzheimer Europe conference.
CEO, Faith Mwangi-Powell, Deputy CEO, Chris Lynch, and Membership Manager, Gloria Mantineo all attended the conference, participating in various events, panels, and excellent meetings.
They also had the opportunity to connect with the ADI members in attendance.
It was also an important opportunity for some of ADI’s global community to meet Faith in-person and have a chance to learn more about her vision for ADI’s future.
A warm thank you to @AlzheimerEurope for their hospitality and for organising an informative and enjoyable conference.
Together, we can work to innovate, share ideas, and ultimately improve the lives of people living with dementia globally, their families, and carers.
Earlier in the week, ADI participated in two major regional initiatives in Santo Domingo: the Ibero-American Dementia Meeting, organised by Asociación Dominicana de Alzheimer y Similares (ADAS), and the Ibero-American Alzheimer’s University, organised by Alzheimer Iberoamérica (AIB).
Diego Aguilar, ADI Regional Director for the Americas, delivered remarks at the opening ceremony, highlighting the vital role of Alzheimer’s associations. He also participated in the inauguration of the Brain Bank at Pedro Henríquez Ureña National University, an important milestone for neuroscience research.
The Ibero-American Alzheimer’s University aims to strengthen the leadership, technical capacity and institutional sustainability of Alzheimer’s associations across the region. As part of the programme, ADI contributed to two strategic modules: public policy, delivered by José María Canelada, author of Argentina’s first provincial Alzheimer’s law, and resource mobilisation, led by Sandra Santillán from AEDROS, the Latin American Association of Fundraising Professionals.
On 11 November, Join ADI for our latest webinar, Innovation in research: Bridging into education, policy and practice.
We are at a pivotal moment in dementia research, advances in diagnostics, biomarkers and disease-modifying treatments are reshaping the dementia landscape. As scientific discoveries accelerate, an important question emerges: how can these developments be translated into meaningful clinical outcomes for people living with dementia, healthcare professionals and policymakers worldwide?
ADI’s latest webinar will explore cutting-edge developments in dementia research, from advances in diagnosis and biomarker science to the challenges and opportunities of translating scientific discoveries into real-world care. Leading experts will discuss advances in clinical trials and the growing importance of biomarkers, alongside the need to equip healthcare professionals, including neurologists, nurses and primary care physicians, with the education and training needed to respond to these developments.
The webinar will also explore the important need to support healthcare systems and professionals with the knowledge, skills and resources required to respond effectively to these rapid advances, helping to ensure that scientific progress translates into better outcomes for people affected by dementia around the world.
Speaker announcements to come.
Register for the webinar: https://t.co/94CrPkLzDs
Yesterday, ADI’s Policy and Communication Officer, Hannah Schneider, attended the Second session of the ‘Intergovernmental Working Group on the human rights of Older Persons’ at the United Nations in Geneva, reiterating ADI’s position that people living with dementia should be explicitly recognised within the legally binding instrument.
In her statement, Hannah highlighted that while dementia is not a part of normal ageing, age is the great risk factor for developing the condition. A dementia diagnosis can impact autonomy, engagement in society and quality of life of older persons and the stigma surrounding dementia can directly affect and limit the care, support, and treatment that people living with dementia can seek out.
Dementia within a legally binding instrument would unambiguously serve as an additional legal safeguard of rights of older persons living with dementia and Alzheimer’s disease, highlighting the need for intersectionality within the instrument and ensuring the protection of those who not only face age-based discrimination but also discrimination on the basis of a condition like dementia or Alzheimer’s.
ADI will continue to engage with this process as it progresses towards a zero draft.
To learn more about the legally binding instrument on the human rights of older persons: https://t.co/Mxp9pu9ssO
We are hiring!
We are seeking an excellent communicator to join our team as Digital Lead.
The successful candidate will have confidence with and experience of digital platforms including social media, email delivery and website content. They will lead on ADI’s digital outputs including the main website, e-Comms, social media and blogs. The will also lead on the management, delivery and analysis of ADI’s monthly e-newsletter, Global Perspective.
Learn more & apply at: https://t.co/HNffu554Vh
ADI Regional Director for the Americas, Diego Aguilar, and the Board of Asociación Dominicana de Alzheimer y Similares (ADAS), ADI’s member association in the Dominican Republic, met with Dr Eladio Pérez, Vice Minister of Health, in Santo Domingo to discuss the future of the country’s national dementia response.
The meeting also brought together senior Ministry of Health officials, including Dr Alejandro Uribe, Director of Mental Health, and Dr Ricardo Elías Melgen, Director of Population Health Management.
Discussions focused on reviewing the National Dementia Plan 2020–2025, with the Vice Minister committing to its renewal. Technical working groups will be established with the participation of ADAS and ADI to support the revision and development of an updated plan, with particular emphasis on measurable indicators to monitor progress and implementation.
The Ministry also confirmed its participation in the upcoming WHO/PAHO Regional Technical Meeting on Dementia, taking place in Mexico City on 9–10 November 2026.
ADI welcomes this important commitment to strengthening the national dementia response and looks forward to continuing its collaboration with the Dominican Republic’s Ministry of Health and ADAS.
Join us online tomorrow, 22 October for a webinar exploring the Alzheimer’s Disease Atlas, a first-of-its-kind resource available to the entire dementia community.
Now covering 137 countries and territories, the AD Atlas compiles pertinent information on diagnosis, treatment and care, policy, research, support for carers, and more, all through an accessible, easy-to-navigate platform.
This webinar will feature commentary from following speakers:
🔴Dr Stéphane Epelbaum, International Therapy Area Lead Medical Affairs Neurology and Pain, Eli Lilly
🔴 Laura Castro-Aldrete, Research Partnerships Lead, ADI
🔴 Patricia Saletti, Research Partnerships Coordinator, ADI
🔴 Dr Kaele Stokes (Morning speaker), Executive Director Services, Engagement and Research, Dementia Australia
🔴Dr Fasihah Irfani (Morning speaker), Associate Professor of Neurology, Universitas Sumatera Utara (USU), Indonesia
🔴 Jaime Parellada Centeno, (Afternoon speaker) Honorary President, Asociación Grupo Ermita Alzheimer, Guatemala
🔴 Kevin Rabiant, (Afternoon speaker) Head of Research Department, France Alzheimer & Maladies Apparentées, France
To accommodate for differing time zones, this free webinar will be held twice, once at 10:00 BST, and again at 16:00 BST.
Register now: https://t.co/pXp0Hkb2FV
ADI's Regional Director for the Americas, Diego Aguilar, participated in AMIIF Innovation Week 2026 in Mexico City, organised by the Mexican Association of Pharmaceutical Research Industries (AMIIF).
Diego joined a panel on “From Patient Testimonies to Co-Designing Solutions”, alongside representatives from diabetes, cancer and patient advocacy organisations.
The discussion highlighted the importance of ensuring that people living with dementia and other health conditions have a meaningful voice in shaping healthcare policies, research and innovation.
Thank you to AMIIF for the invitation and for bringing these important conversations together.
#DementiaAdvocacy
From 15–16 October 2026, Alzheimer’s Disease International (ADI) conducted an on-site accreditation assessment visit to Advanced Gerontological Education Inc. (AGE) in Hamilton, Ontario, as part of ADI’s Accreditation Programme.
Amalia Fonk-Utomo, Head of Accreditation, travelled to Canada alongside Dawn Brooker and Bill Yeates, who were representing the ADI Global Review Panel.
Over the two days, the team observed dementia training in practice and held valuable discussions with AGE leadership, trainers, programme developers and key stakeholders.
The visit provided an important opportunity to observe AGE’s real-world delivery of dementia training and explore opportunities for growth and improvement. ADI extends its appreciation to the AGE team for their warm welcome, sincerity, and collaboration throughout the visit, and to the Global Review Panel members for their valuable contributions.
The accreditation review process is ongoing, with further updates to follow.
Together, we continue to support quality dementia education and training worldwide.
#ADIAccreditation #DementiaEducation #DementiaTraining #AGE